• Explore /
  • Poster
  • / Superior overall survival (OS), progression-free survival (PFS), and clinical response (CR) predictions for patients with non-small cell lung cancer (NSCLC) using Cellworks Singula: myCare-022-05.

Superior overall survival (OS), progression-free survival (PFS), and clinical response (CR) predictions for patients with non-small cell lung cancer (NSCLC) using Cellworks Singula: myCare-022-05.

Abstract Poster

Authors

null

Vamsidhar Velcheti

Cleveland Clinic Foundation, Cleveland, OH

Vamsidhar Velcheti , Michael Castro , Drew Watson , Shweta Kapoor , Anuj Tyagi , Mohammed Sauban , Aftab Alam , Kunal Ghosh Roy , Swaminathan Rajagopalan , Shruthi Kulkarni , Nirjhar Mundkur , Jim Christie , Rakhi Purushothaman Suseela , Adity Ghosh , Kabya Basu , Diwyanshu Sahu , Yashaswini Ullal , Prashant Nair , Manmeet Singh Ahluwalia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 9117)

DOI

10.1200/JCO.2021.39.15_suppl.9117

Abstract #

9117

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Patrick Y. Wen

First Author: Elizabeth Catherine Smyth

First Author: Jeffrey C. Thompson

First Author: Boris M Pfeiffer